U.S. Entertainment Stock News

The UAE General Civil Aviation Authority recently moved Archer Aviation’s Midnight electric air taxi into a Restricted Type Certificate program, creating a more streamlined regulatory path toward limited commercial operations in the country. This makes Archer the first eVTOL manufacturer on this certification track in the UAE, underscoring how international regulators may help accelerate its commercialization efforts. We’ll now explore how this UAE certification fast-track could influence...

In late April 2026, Webster Financial Corporation reported first-quarter 2026 results showing higher net interest income of US$634.4 million and net income of US$246.23 million compared with the prior year, alongside lower total net charge-offs of US$41.22 million, while its Board declared regular quarterly dividends on common and Series F and G preferred shares payable in mid-2026. This combination of earnings growth, reduced credit losses and continued common and preferred dividend...

What the raised outlook means for W.W. Grainger stock W.W. Grainger (GWW) raised its 2026 outlook after reporting first quarter results that exceeded analyst expectations, pairing the guidance move with a higher quarterly dividend and fresh capacity to issue debt securities. For investors, this cluster of updates gives new information on three fronts at once: earnings power, balance sheet flexibility, and cash returns. The updated full year guidance now calls for net sales between US$19.2b...

SES AI stock performance snapshot SES AI (SES) has drawn fresh attention as investors reassess high risk battery technology stocks, with the share price recently closing at US$0.92 and the market cap sitting near US$362.7m. See our latest analysis for SES AI. The recent 1 day share price return of a 6.24% decline, alongside a 7 day share price return of a 12.29% decline and a 90 day share price return of a 51.01% decline, contrasts with a 1 year total shareholder return of 2.19%. This...

Sylvamo (SLVM) is back in focus after first quarter 2026 results showed sales of US$755 million and a net loss of US$3 million, as mill investments and reliability issues weighed on operations. See our latest analysis for Sylvamo. The stock has been under pressure this year, with an 8.54% year to date share price decline and a 24.51% 1 year total shareholder return decline. This comes despite a recent 6.17% 1 month share price gain, which hints at tentative momentum following the weak quarter...

Q1 2026 earnings put Eve Holding in focus Eve Holding (EVEX) is back on investors’ radar after reporting a wider first quarter 2026 loss, updating its eVTOL commercialization timeline, and outlining progress on certification and prototype flight testing. See our latest analysis for Eve Holding. The earnings update and prototype milestones have come after a mixed run for the stock, with a 24.9% 1 month share price return but a 23.39% year to date share price decline and a 59.82% 3 year total...

First quarter earnings put Pediatrix Medical Group in focus Pediatrix Medical Group (MD) is back on investors’ radar after its latest first quarter report, which showed higher sales, net income and earnings per share compared with the same period a year earlier. See our latest analysis for Pediatrix Medical Group. The earnings update appears to have reset expectations around Pediatrix Medical Group, with a 9.77% 90 day share price return and a 58.79% 1 year total shareholder return indicating...

ProFrac Holding (ACDC) stock is in focus after first quarter 2026 results showed sales of US$449.6 million and a net loss of US$83.5 million, with revenue exceeding analyst expectations. See our latest analysis for ProFrac Holding. The earnings surprise and wider loss have coincided with a 7.71% 1 day share price return decline and a 12.73% 7 day share price return decline. However, the 62.87% year to date share price return and 65.53% 1 year total shareholder return suggest earlier momentum...

In the first quarter of 2026, Elanco Animal Health reported revenue of US$1,371 million versus US$1,193 million a year earlier, while net income eased to US$57 million from US$67 million and earnings per share from continuing operations slipped to US$0.11. Alongside raising full-year 2026 revenue guidance to a range of US$5.01 billion to US$5.09 billion and issuing second-quarter revenue guidance of US$1,300 million to US$1,325 million, Elanco highlighted innovation-led growth from products...

Why AerCap’s new buyback and guidance matter for investors AerCap Holdings (NYSE:AER) is back in focus after reporting a record quarter for aviation leasing, lifting its 2026 adjusted earnings guidance and authorizing a fresh US$1.0b share repurchase program. The results highlight how management is using higher earnings, strong demand for aircraft assets and cash generation to return capital through both buybacks and a US$0.40 quarterly dividend, while several analysts reassess their views on...

Recent share performance and business snapshot Newmark Group (NMRK) has drawn fresh attention after recent share price moves, with the stock showing a 1.6% return over the past day and 4.7% over the past week, alongside a 15.2% return over the past month. Over the past 3 months, Newmark Group’s return has been close to flat at 0.1%. Year to date, the stock shows a 0.6% decline, set against a 50.3% total return over the past year and a 3 year total return multiple of roughly 2.3x. At a last...

Why Peoples Bancorp Stock Is On Investors’ Radar Today Peoples Bancorp (PEBO) is drawing fresh attention after recent trading, with the stock last closing at $34.28. That puts recent returns, valuation metrics and its banking-focused business back in focus for investors. See our latest analysis for Peoples Bancorp. While the 1 day and 7 day share price returns were slightly negative, the stock’s 13.66% year to date share price return and 22.06% 1 year total shareholder return suggest momentum...

Veralto (VLTO) has been in focus after reporting first quarter 2026 results alongside a completed share buyback, giving investors fresh data on sales, profitability, and how management is deploying capital. See our latest analysis for Veralto. Despite the solid first quarter update and the completion of the share repurchase program, Veralto’s recent share price return has been muted. The 1-day share price return of 2.13% contrasts with a year-to-date share price return decline of 9.92% and a...

NMI Holdings, Inc. reported past first-quarter 2026 results with revenue rising to US$183.48 million while net income eased to US$99.33 million, and also recently presented at the BTIG Housing and Real Estate Conference in New York. Management’s emphasis on disciplined expense control, resilient demand for down payment support, and stable reserve assumptions provides a clearer view of how the insurer is managing credit trends in a changing housing backdrop. We’ll now explore how this...

Why Casella Waste Systems stock is in focus after revised 2026 guidance Casella Waste Systems (CWST) has drawn investor attention after revising its 2026 outlook, lifting expected revenues to a range of US$2.060b to US$2.080b while cutting projected net income to US$4 million to US$10 million. This update arrived alongside first quarter results to March 31, 2026, with sales of US$457.33 million compared with US$417.10 million a year earlier and a net loss of US$5.54 million compared with...

In early May 2026, Expedia Group reported Q1 2026 results with US$3,426 million in sales, a US$6 million net loss, confirmed its 2026 revenue outlook, announced a new up to US$5 billion share repurchase authorization after completing a prior US$4.13 billion buyback, and affirmed a US$0.48 quarterly cash dividend payable on June 18, 2026. An interesting angle is how Expedia is pairing strong Q1 earnings and AI-driven efficiency gains with substantial capital returns through large-scale...

Boise Cascade (BCC) is back in focus after first quarter 2026 results showed lower sales and net income versus a year earlier, even as the company exceeded revenue and EPS expectations and issued cautious EBITDA guidance. See our latest analysis for Boise Cascade. At a share price of US$72.76, Boise Cascade has seen recent share price pressure, with a 7 day share price return of 8.21% and a 90 day share price return of 20.07%. The 1 year total shareholder return of 17.92% contrasts with...

If you are wondering whether Revvity at around US$98.85 is offering value or is simply noise in your watchlist, this breakdown can help frame what the current price might be implying. The stock has been active recently, with returns of 14.1% over 7 days, 12.6% over 30 days, 0.7% year to date and 6.7% over 1 year, alongside longer term returns of a 15.8% decline over 3 years and a 29.2% decline over 5 years. These mixed returns indicate short term optimism combined with longer term caution,...

In early May 2026, Artivion, Inc. reported first‑quarter revenue of US$116.34 million, up from US$98.98 million a year earlier, and moved from a small net loss to a net income of US$1.42 million while also announcing plans to acquire Endospan following FDA approval of the NEXUS Aortic Arch System. Despite this topline growth and portfolio expansion, Artivion missed profit expectations and lowered its full‑year 2026 revenue and adjusted EBITDA guidance, highlighting near‑term operational...

Why Madison Square Garden Sports (MSGS) is Back on Investor Radars Madison Square Garden Sports (MSGS) stock has been drawing fresh attention after posting annual revenue of US$1,071.0 million and net income of US$16.6 million, prompting investors to reassess how this professional sports company is currently valued. See our latest analysis for Madison Square Garden Sports. At a share price of US$332.52, Madison Square Garden Sports has seen a 19.06% 90 day share price return and a 74.18% 1...

In early May 2026, Gilead Sciences reported first-quarter revenue of US$6.96 billion and net income of US$2.02 billion, while also completing a multi-year US$4.57 billion share repurchase program and filing a US$6.51 billion shelf registration for up to 47,750,000 common shares. At the same time, the FDA accepted Gilead’s New Drug Application for its once-daily bictegravir/lenacapavir HIV regimen with priority review, underscoring how strong HIV portfolio performance and an advancing...

Why Crane NXT stock is back in focus after Q1 Crane NXT (CXT) is drawing fresh attention after first quarter 2026 revenue and adjusted earnings topped expectations, helped by the Antares Vision acquisition and firm demand in Security and Authentication Technologies. See our latest analysis for Crane NXT. The latest results and acquisition update have arrived after a mixed share price run, with a 30 day share price return of 5.40% but a 1 year total shareholder return decline of 12.80%. If Q1...

BlackLine, Inc. recently reported first-quarter 2026 results, with GAAP revenue of US$183.16 million and net income of US$8.13 million, and issued guidance calling for second-quarter GAAP revenue of US$186 million to US$188 million and full-year 2026 GAAP revenue of US$765 million to US$769 million. Management’s decision to raise full-year guidance and highlight growing adoption of its AI-powered financial automation platform underlines how operational progress is increasingly shaping...

Arista Networks (ANET) moved into focus after first quarter 2026 results and fresh guidance highlighted strong AI networking demand along with ongoing supply constraints, leaving the stock volatile as investors reassessed growth expectations. See our latest analysis for Arista Networks. The shares have swung sharply, with a 7 day share price return of negative 17.9% and a 1 day move of negative 3.6%. This is in contrast to the 1 year total shareholder return of 62.4% and the 5 year total...